Divalmac-250 Tablet

Divalproex Sodium 250 mg Extended Release Tablets

Divalmac-250 Tablet — Divalproex 250 mg Extended Release from Trumac Healthcare PCD Pharma Franchise India

Composition Divalproex 250 mg Extended Release
Dosage Form Extended Release Tablet
Pack Type Alu-Alu Blister
Pack Size 10 x 10 Tablets
MRP ₹ 979
Therapy Neurology — Antiepileptic + Mood Stabiliser
Storage Store below 30 °C in a dry place, protected from light and moisture.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Divalmac-250 Tablet

Divalmac-250 ER Tablet contains Divalproex Sodium 250 mg in an extended-release format — a stable coordination compound containing valproic acid and sodium valproate in 1:1 molar ratio. Used for epilepsy, bipolar disorder maintenance and migraine prophylaxis.

Divalproex provides broad-spectrum antiepileptic activity covering generalised tonic-clonic, absence, myoclonic and focal seizures. The ER formulation supports once-daily dosing with smoother plasma levels.

Manufactured by Trumac Healthcare under WHO-GMP. Available for monopoly-based PCD pharma franchise and third-party manufacturing.

Indications

  • Generalised and focal-onset seizures
  • Bipolar disorder (manic episodes & maintenance)
  • Migraine prophylaxis
  • Status epilepticus (alternative formulations)

Mechanism of Action

Divalproex enhances GABA-ergic neurotransmission and modulates voltage-gated sodium channels. Inhibits histone deacetylase. Broad mechanism produces wide-spectrum antiepileptic activity.

Dosage & Administration

Adults: 500–1000 mg/day in 1–2 divided doses; titrate based on serum levels (50–100 mcg/ml). Adjust in hepatic impairment.

Side Effects

GI upset, weight gain, tremor, hair loss, elevated liver enzymes. Serious: hepatotoxicity, pancreatitis, thrombocytopenia, teratogenic.

Contraindications & Precautions

Pregnancy (highly teratogenic — neural tube defects). Hepatic disease. Urea cycle disorders. Mitochondrial disorders.

Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise & Third-Party Manufacturing
Divalmac-250 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Divalmac-250 Tablet used for?

Divalmac-250 Tablet contains Divalproex 250 mg Extended Release. Used as per the indications described above.

How should Divalmac-250 Tablet be taken?

As directed by your physician. Complete the prescribed course.

Is Divalmac-250 Tablet available for PCD pharma franchise?

Yes, Trumac Healthcare offers Divalmac-250 Tablet on monopoly-based PCD pharma franchise and for third-party manufacturing.

How should Divalmac-250 Tablet be stored?

Store below 30 °C in a dry place, protected from light and moisture.

Is Divalmac-250 Tablet WHO-GMP certified?

Yes, manufactured in WHO-GMP and DCGI-compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.